Cargando…
SPOP promotes CDCA5 degradation to regulate prostate cancer progression via the AKT pathway
The E3 ubiquitin ligase adaptor Speckle-type POZ protein (SPOP) plays an important tumour suppressor role in prostate cancers (PCa), with mutation rate up to 15%. However, how SPOP mutations regulate prostate tumorigenesis remains elusive. Here, we report the identification of cell division cycle as...
Autores principales: | Luo, Zhenzhen, Wang, Jing, Zhu, Yue, Sun, Xiao, He, Chenchen, Cai, Mengjiao, Ma, Jinlu, Wang, Yi, Han, Suxia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Neoplasia Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8435818/ https://www.ncbi.nlm.nih.gov/pubmed/34509929 http://dx.doi.org/10.1016/j.neo.2021.08.002 |
Ejemplares similares
-
The SPOP-ITCH Signaling Axis Protects Against Prostate Cancer Metastasis
por: Ma, Jinlu, et al.
Publicado: (2021) -
SPOP promotes ATF2 ubiquitination and degradation to suppress prostate cancer progression
por: Ma, Jian, et al.
Publicado: (2018) -
SPOP suppresses pancreatic cancer progression by promoting the degradation of NANOG
por: Tan, Peng, et al.
Publicado: (2019) -
CDCA5 promotes the progression of prostate cancer by affecting the ERK signalling pathway
por: Ji, Junpeng, et al.
Publicado: (2021) -
SPOP promotes ubiquitination and degradation of LATS1 to enhance kidney cancer progression
por: Wang, Lixia, et al.
Publicado: (2020)